- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Panitumumab – November 2013
Panitumumab, 100 mg/5 ml and 400 mg/20 ml injection, Vectibix®
Last updated
8 November 2023